Paul Berns
Investing Profile
Sweet spot: $25M
Range: $50K–$150M
Fund: $635.8M
ARCH Venture Partners thesis
Disruptive Companies Explore our portfolio Great Science Learn about ARCH Amazing Teams Meet our entrepreneurs ⬤ ⬤ ⬤ We’re catalyzing discoveries that prevent, detect, and cure disease. Testimonials Read what our entrepreneurs are saying about ARCH. "...I continually marvel at [ARCH's] deep involvement and commitment." Jay Flatley, Executive Chairman "[ARCH] is committed to building truly transformational companies..." Hans Bishop, Former CEO "There is no other venture firm like ARCH." Ryan Watts, Ph.D., CEO "ARCH is unique in its ability to see the waves before they start to form." David Sche
Sector and stage focus
- Series B: BioTech, Pharmaceuticals
- general: San Francisco Bay Area
Is Paul Berns a fit for your round?
Upload your pitch deck and see whether Paul Berns appears in your top 20 matches.
Find investors for your deck